Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (260)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mutation
21
2022
1292
1.760
 Why?
Multiple Myeloma
38
2023
2916
1.730
 Why?
High-Throughput Nucleotide Sequencing
5
2021
168
1.030
 Why?
Translocation, Genetic
14
2021
263
0.990
 Why?
Oncogenes
2
2018
57
0.740
 Why?
Biliary Tract Neoplasms
1
2018
9
0.610
 Why?
Gene Expression Profiling
14
2022
1028
0.600
 Why?
Cholangiocarcinoma
1
2018
26
0.600
 Why?
Genomics
8
2022
284
0.550
 Why?
Proto-Oncogene Proteins B-raf
3
2022
78
0.530
 Why?
Gene Expression Regulation, Neoplastic
11
2022
824
0.530
 Why?
Prognosis
15
2021
1957
0.430
 Why?
Brain Neoplasms
3
2023
282
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
994
0.400
 Why?
Gene Dosage
5
2020
78
0.400
 Why?
Genetic Predisposition to Disease
5
2018
508
0.390
 Why?
Plasma Cells
4
2021
221
0.380
 Why?
Genome, Human
4
2021
110
0.360
 Why?
Evolution, Molecular
2
2021
97
0.360
 Why?
Liver Neoplasms
3
2022
329
0.360
 Why?
Humans
51
2023
49929
0.350
 Why?
DNA Mutational Analysis
7
2020
176
0.340
 Why?
Thalidomide
5
2019
374
0.340
 Why?
DNA Copy Number Variations
4
2021
108
0.330
 Why?
In Situ Hybridization, Fluorescence
11
2023
256
0.320
 Why?
Software
2
2021
273
0.310
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
111
0.300
 Why?
Neoplasm Recurrence, Local
3
2021
626
0.290
 Why?
Chromosome Aberrations
6
2022
295
0.280
 Why?
Carcinoma, Hepatocellular
2
2022
194
0.280
 Why?
Polymorphism, Single Nucleotide
3
2018
483
0.270
 Why?
Epigenesis, Genetic
4
2018
370
0.260
 Why?
Clonal Evolution
2
2019
56
0.260
 Why?
Chromosomes, Human, Pair 1
2
2019
92
0.250
 Why?
Immunoglobulin Heavy Chains
3
2014
41
0.250
 Why?
Neoplasm Proteins
3
2017
321
0.240
 Why?
Disease Progression
8
2021
820
0.240
 Why?
Gene Regulatory Networks
2
2022
107
0.230
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
23
0.220
 Why?
Polycomb Repressive Complex 2
2
2021
46
0.210
 Why?
Male
25
2021
25454
0.210
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.210
 Why?
Female
26
2021
26576
0.210
 Why?
Central Nervous System Neoplasms
1
2023
64
0.210
 Why?
Exome
4
2017
46
0.210
 Why?
STAT2 Transcription Factor
1
2021
6
0.200
 Why?
STAT1 Transcription Factor
1
2021
25
0.200
 Why?
Germ-Line Mutation
2
2021
61
0.200
 Why?
Hematologic Neoplasms
1
2023
98
0.200
 Why?
Li-Fraumeni Syndrome
1
2021
12
0.200
 Why?
Middle Aged
17
2021
12293
0.190
 Why?
Aged
15
2021
9449
0.190
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Japan
2
2018
26
0.190
 Why?
Aged, 80 and over
9
2021
3138
0.180
 Why?
Gene Frequency
2
2017
96
0.180
 Why?
Ecosystem
1
2021
64
0.180
 Why?
Neoplasms
2
2020
1234
0.180
 Why?
Glioblastoma
1
2021
88
0.180
 Why?
Cell Cycle
1
2021
226
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Leukemia, Plasma Cell
1
2020
33
0.170
 Why?
DNA Methylation
3
2016
544
0.170
 Why?
Chromosomal Instability
1
2019
16
0.170
 Why?
Genes, myc
1
2019
40
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
31
0.160
 Why?
Diploidy
2
2017
26
0.160
 Why?
Cell Survival
2
2018
590
0.160
 Why?
Chromosomes, Human, Pair 11
3
2014
54
0.160
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Genes, Tumor Suppressor
2
2021
73
0.150
 Why?
Adult
13
2021
13356
0.150
 Why?
Mutagenesis
1
2018
59
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.150
 Why?
Transcriptional Elongation Factors
1
2017
17
0.150
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.150
 Why?
Histone-Lysine N-Methyltransferase
2
2016
57
0.150
 Why?
Transcriptome
4
2021
312
0.150
 Why?
Enhancer Elements, Genetic
1
2017
58
0.140
 Why?
Reproducibility of Results
1
2021
1182
0.140
 Why?
Chromosomes, Human
1
2017
41
0.140
 Why?
Melanoma
1
2020
281
0.140
 Why?
Hepatocytes
1
2018
179
0.140
 Why?
Immunologic Factors
1
2017
112
0.140
 Why?
B-Lymphocytes
2
2016
175
0.140
 Why?
Neoplasms, Multiple Primary
1
2016
42
0.130
 Why?
Neoplasm Metastasis
1
2016
235
0.130
 Why?
Melphalan
2
2013
173
0.130
 Why?
Oligodendroglioma
1
2015
6
0.130
 Why?
Sequence Analysis, DNA
2
2016
237
0.120
 Why?
Endoribonucleases
1
2015
15
0.120
 Why?
ras Proteins
1
2015
65
0.120
 Why?
Skin Neoplasms
1
2020
487
0.120
 Why?
Survival Rate
4
2020
905
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
40
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
42
0.120
 Why?
Survival Analysis
5
2015
670
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.120
 Why?
Signal Transduction
5
2022
1608
0.120
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.120
 Why?
Mutation Rate
3
2021
36
0.120
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Chromosome Deletion
2
2011
138
0.110
 Why?
Transcription Factors
2
2015
565
0.110
 Why?
Kaplan-Meier Estimate
4
2018
463
0.110
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
RNA, Neoplasm
1
2013
45
0.110
 Why?
Nerve Tissue Proteins
1
2015
192
0.110
 Why?
Cell Line, Tumor
4
2022
1388
0.110
 Why?
Chromosome Breakage
1
2013
16
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
7
0.110
 Why?
Repressor Proteins
1
2014
149
0.110
 Why?
Germinal Center
1
2013
28
0.110
 Why?
RNA Splicing
3
2021
37
0.100
 Why?
Genetic Heterogeneity
1
2012
18
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
181
0.100
 Why?
DNA-Binding Proteins
1
2015
424
0.100
 Why?
Acetyltransferases
1
2011
19
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
26
0.100
 Why?
RNA, Messenger
1
2015
1099
0.100
 Why?
Antineoplastic Agents
3
2018
1175
0.100
 Why?
Chromosomes, Human, Pair 17
1
2011
35
0.100
 Why?
DNA, Neoplasm
3
2018
145
0.090
 Why?
Cell Proliferation
3
2022
986
0.090
 Why?
Multivariate Analysis
3
2021
579
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
76
0.090
 Why?
Phenotype
3
2022
728
0.090
 Why?
Remission Induction
2
2021
205
0.090
 Why?
Tumor Suppressor Protein p53
1
2011
213
0.080
 Why?
Clone Cells
2
2021
78
0.080
 Why?
MicroRNAs
1
2013
347
0.080
 Why?
DNA
1
2012
543
0.080
 Why?
Alleles
2
2021
252
0.080
 Why?
Transcriptional Activation
2
2021
121
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Follow-Up Studies
3
2020
2177
0.070
 Why?
Genomic Instability
2
2018
91
0.070
 Why?
Epigenomics
2
2017
67
0.070
 Why?
Risk Factors
3
2021
3605
0.070
 Why?
Loss of Heterozygosity
2
2018
77
0.060
 Why?
Disease-Free Survival
2
2019
450
0.060
 Why?
Treatment Outcome
4
2019
5178
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
656
0.060
 Why?
Liver
2
2022
1106
0.060
 Why?
Genotype
2
2017
539
0.050
 Why?
Histones
2
2016
295
0.050
 Why?
Dexamethasone
2
2019
424
0.050
 Why?
Proportional Hazards Models
2
2015
404
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
25
0.050
 Why?
Nitriles
1
2021
52
0.050
 Why?
Gene Rearrangement
1
2022
73
0.050
 Why?
Organoids
1
2021
36
0.050
 Why?
Syndecan-1
1
2021
72
0.050
 Why?
Microarray Analysis
2
2012
73
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Chromosome Mapping
2
2011
158
0.050
 Why?
Polymerase Chain Reaction
2
2013
456
0.050
 Why?
Cell Movement
1
2022
245
0.050
 Why?
Cell Line
2
2015
1010
0.050
 Why?
Pyrazoles
1
2021
111
0.050
 Why?
Alternative Splicing
1
2021
57
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
 Why?
Phosphoproteins
1
2021
111
0.040
 Why?
Pyrimidines
1
2021
192
0.040
 Why?
Gene Expression
2
2013
612
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2345
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
658
0.040
 Why?
Young Adult
2
2021
4031
0.040
 Why?
Maintenance Chemotherapy
1
2019
49
0.040
 Why?
Syndrome
1
2019
237
0.040
 Why?
Transcription Elongation, Genetic
1
2017
2
0.040
 Why?
Physical Chromosome Mapping
1
2017
7
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
106
0.040
 Why?
Caspases
1
2018
104
0.040
 Why?
Genetic Loci
1
2017
44
0.040
 Why?
Unfolded Protein Response
1
2017
32
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
212
0.040
 Why?
Molecular Targeted Therapy
1
2018
121
0.040
 Why?
Mitosis
1
2017
88
0.040
 Why?
Genetic Association Studies
1
2017
115
0.030
 Why?
Algorithms
1
2020
613
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Virus Integration
1
2016
8
0.030
 Why?
Comparative Genomic Hybridization
1
2016
46
0.030
 Why?
Risk
1
2017
314
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
42
0.030
 Why?
Computational Biology
1
2018
214
0.030
 Why?
Nuclear Proteins
1
2017
242
0.030
 Why?
Immunosuppressive Agents
1
2017
226
0.030
 Why?
Tumor Microenvironment
1
2017
221
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
457
0.030
 Why?
RNA Stability
1
2015
24
0.030
 Why?
Patient Selection
1
2016
254
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
19
0.030
 Why?
Amino Acid Sequence
1
2016
579
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
11
0.030
 Why?
Cytogenetic Analysis
1
2014
80
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
470
0.030
 Why?
Time Factors
1
2021
2891
0.030
 Why?
Introns
1
2014
50
0.030
 Why?
Single-Cell Analysis
1
2014
63
0.030
 Why?
Methylation
1
2014
118
0.030
 Why?
Protein Isoforms
1
2014
118
0.030
 Why?
Down-Regulation
1
2015
342
0.030
 Why?
Base Sequence
1
2015
657
0.030
 Why?
High-Throughput Screening Assays
1
2013
35
0.030
 Why?
Protein Structure, Tertiary
1
2014
249
0.030
 Why?
HeLa Cells
1
2014
257
0.030
 Why?
Molecular Sequence Data
1
2015
799
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
82
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Mass Spectrometry
1
2014
283
0.030
 Why?
Transforming Growth Factor beta1
1
2013
60
0.030
 Why?
Early Detection of Cancer
1
2014
163
0.030
 Why?
Homologous Recombination
1
2013
40
0.030
 Why?
Disease Models, Animal
1
2018
1411
0.030
 Why?
Tumor Suppressor Proteins
1
2013
127
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Apoptosis
1
2018
1092
0.030
 Why?
Gene Library
1
2012
42
0.030
 Why?
Laboratories
1
2012
20
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
907
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
314
0.020
 Why?
Animals
2
2018
13100
0.020
 Why?
Bone Marrow
1
2013
351
0.020
 Why?
Breast Neoplasms
1
2020
1184
0.020
 Why?
Vincristine
1
2010
84
0.020
 Why?
Prednisolone
1
2010
55
0.020
 Why?
Adolescent
1
2021
6417
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
409
0.020
 Why?
Cluster Analysis
1
2010
233
0.020
 Why?
Precancerous Conditions
1
2010
83
0.020
 Why?
Cyclophosphamide
1
2010
163
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.020
 Why?
Clinical Trials as Topic
1
2012
466
0.020
 Why?
Stem Cell Transplantation
1
2010
179
0.020
 Why?
Child
1
2021
6849
0.020
 Why?
Sex Factors
1
2011
692
0.020
 Why?
Models, Biological
1
2012
719
0.020
 Why?
Doxorubicin
1
2010
233
0.020
 Why?
Up-Regulation
1
2010
446
0.020
 Why?
Risk Assessment
1
2013
1255
0.020
 Why?
Prevalence
1
2011
956
0.020
 Why?
Mice
1
2018
5658
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (260) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department